Breast cancer is one of the most common cancers affecting women worldwide. It occurs when cells in the breast grow uncontrollably, forming a tumor....

Wednesday, October 23, 2024 -- The National Institutes of Health (NIH) has launched a proof-of-concept precision medicine clinical trial to test new...

All cancer mutations that cause drug resistance fall into one of four categories. New research has detailed each type, helping to uncover targets for...

According to experts, AI can transform India's heart disease treatment with early diagnosis and personalized care.

Explore how mAbs are transforming disease treatment, the evolution from murine to humanized antibodies, and the impact of biosimilar antibodies on...

The Cancer Association of Namibia (CAN) is calling on all Namibians to join the fight against breast cancer by participating in #PinkFriday2024 on 25...

Despite significant advancements in cancer treatment, drug resistance remains a persistent challenge. Cancer cells can often develop resistance to...

While often perceived as a women's disease, breast cancer affects men as well. Stigma, however, can delay diagnosis and treatment, potentially...

Scientists are developing advanced tools to understand and treat neurological symptoms such as brain fog associated with respiratory diseases like...

WEDNESDAY, Oct. 23, 2024 -- The U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and...